{"id":73566,"date":"2013-02-27T15:51:27","date_gmt":"2013-02-27T20:51:27","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/bg-medicine-inc-to-present-at-cowen-and-company-33rd-annual-health-care-conference.php"},"modified":"2013-02-27T15:51:27","modified_gmt":"2013-02-27T20:51:27","slug":"bg-medicine-inc-to-present-at-cowen-and-company-33rd-annual-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/bg-medicine-inc-to-present-at-cowen-and-company-33rd-annual-health-care-conference.php","title":{"rendered":"BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference"},"content":{"rendered":"<p><p>      WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- BG      Medicine, Inc. (BGMD)      ), a company focused on the development and commercialization      of novel cardiovascular diagnostics, announced today that      Eric Bouvier, BG Medicine's President and CEO, will be      presenting at the Cowen and Company 33rd Annual Health Care      Conference on March 4, 2013, at the Boston Marriott Copley      Place, beginning at 2:10 PM Eastern Time (ET).    <\/p>\n<p>      Audio and slides of BG Medicine's presentation will be      webcast at:       <a href=\"http:\/\/wsw.com\/webcast\/cowen10\/bgmd\/\" rel=\"nofollow\">http:\/\/wsw.com\/webcast\/cowen10\/bgmd\/<\/a>.    <\/p>\n<p>      The webcast will be archived for 30 days following the live      presentation on BG Medicine's Investor Relations website at      ir.BG-medicine.com.    <\/p>\n<p>      About BG Medicine    <\/p>\n<p>      BG Medicine, Inc. (BGMD)      is a diagnostics company focused on the development and      commercialization of novel cardiovascular tests to address      significant unmet medical needs, improve patient outcomes and      reduce healthcare costs. The Company has two products: the      BGM Galectin-3(R) test for use in patients with chronic heart      failure is available in the United States and Europe; and the      CardioSCORE(TM) test for the risk prediction of major      cardiovascular events will be launched in Europe in the first      half of 2013. For additional information about BG Medicine,      heart failure and galectin-3 testing, please visit <a href=\"http:\/\/www.bg-medicine.com\" rel=\"nofollow\">http:\/\/www.bg-medicine.com<\/a> and <a href=\"http:\/\/www.galectin-3.com\" rel=\"nofollow\">http:\/\/www.galectin-3.com<\/a>.    <\/p>\n<p>      The BG Medicine Inc. logo is available at       <a href=\"http:\/\/www.globenewswire.com\/newsroom\/prs\/?pkgid=10352\" rel=\"nofollow\">http:\/\/www.globenewswire.com\/newsroom\/prs\/?pkgid=10352<\/a>.    <\/p>\n<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/bg-medicine-inc-present-cowen-133000174.html;_ylt=A2KLOzK8cS5RB18AhTr_wgt.\" title=\"BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference\">BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD) ), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Eric Bouvier, BG Medicine's President and CEO, will be presenting at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013, at the Boston Marriott Copley Place, beginning at 2:10 PM Eastern Time (ET) <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/bg-medicine-inc-to-present-at-cowen-and-company-33rd-annual-health-care-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-73566","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/73566"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=73566"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/73566\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=73566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=73566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=73566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}